NIK-12192
NIK-12192 is an orally active inhibitor of vacuolar H+-ATPase. NIK-12192 reduces intracellular pH, decreases lysosomal volume and acidity, and alters the intracellular localization of V-ATPase by inhibiting proton pumps. NIK-12192 induces αvβ5 integrin polarization, cytoskeletal disruption, cell detachment, anoikis-mediated delayed apoptosis and necrosis, a delayed reduction in mitochondrial membrane potential, and lysosomal/phagosomal accumulation. NIK-12192 inhibits tumor cell migration, invasion, and three-dimensional spheroid growth, and enhances the activity of Topotecan (HY-13768). NIK-12192 suppresses spontaneous lung metastasis in vivo. NIK-12192 is used in research related to colon cancer, ovarian cancer, lung cancer, breast cancer, renal cancer, prostate cancer, acute myeloid leukemia, and melanoma.
For research use only. We do not sell to patients.
- CAS No.: 318262-42-9
- Formula: C26H31Cl2N3O2
- Molecular Weight:488.45
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biological Activity
Description
Cellular Effect
|
Cell Line
|
Type | Value | Description | References |
|---|---|---|---|---|
| HT-29 | IC50 |
1.06 μM
|
Antiproliferative activity against human colon carcinoma HT29 cells assessed by measuring protein content incubated for 72 hrs by sulforhodamine B assay.
Antiproliferative activity against human colon carcinoma HT29 cells assessed by measuring protein content incubated for 72 hrs by sulforhodamine B assay.
|
19723111 |
| LoVo | IC50 |
2.51 μM
|
Antiproliferative activity against human colon carcinoma LoVo cells assessed by measuring protein content incubated for 72 hrs by sulforhodamine B assay.
Antiproliferative activity against human colon carcinoma LoVo cells assessed by measuring protein content incubated for 72 hrs by sulforhodamine B assay.
|
19723111 |
| HCT-116 | IC50 |
2.58 μM
|
Antiproliferative activity against human colon carcinoma HCT116 cells assessed by measuring protein content incubated for 72 hrs by sulforhodamine B assay.
Antiproliferative activity against human colon carcinoma HCT116 cells assessed by measuring protein content incubated for 72 hrs by sulforhodamine B assay.
|
19723111 |
| NCI-H460 | IC50 |
2.20 μM
|
Antiproliferative activity against human large-cell lung carcinoma H460 cells assessed by measuring protein content incubated for 72 hrs by sulforhodamine B assay.
Antiproliferative activity against human large-cell lung carcinoma H460 cells assessed by measuring protein content incubated for 72 hrs by sulforhodamine B assay.
|
19723111 |
| POVD | IC50 |
2.53 μM
|
Antiproliferative activity against human small-cell lung carcinoma POVD cells assessed by measuring metabolic activity incubated for 72 hrs by MTT assay.
Antiproliferative activity against human small-cell lung carcinoma POVD cells assessed by measuring metabolic activity incubated for 72 hrs by MTT assay.
|
19723111 |
| OVCAR-3 | IC50 |
2.58 μM
|
Antiproliferative activity against human ovarian carcinoma OVCAR-3 cells assessed by measuring protein content incubated for 72 hrs by sulforhodamine B assay.
Antiproliferative activity against human ovarian carcinoma OVCAR-3 cells assessed by measuring protein content incubated for 72 hrs by sulforhodamine B assay.
|
19723111 |
| HL-60 | IC50 |
2.86 μM
|
Antiproliferative activity against human acute myelocytic leukemia HL60 cells assessed by measuring protein content incubated for 72 hrs by sulforhodamine B assay.
Antiproliferative activity against human acute myelocytic leukemia HL60 cells assessed by measuring protein content incubated for 72 hrs by sulforhodamine B assay.
|
19723111 |
In Vitro
NIK-12192 (5 μM; 48-96 h) reduces the volume and/or acidity of lysosomes in the human colon cancer cell line HT29 in a time-dependent manner[1].
NIK-12192 (1 μM; 16 h) induces the accumulation of lysosomes and phagosomes (but not autophagosomes) in human colon cancer HT29 cells, indicating impaired organelle fusion[1].
NIK-12192 (1 μM; 20-120 min) localizes predominantly in the cytoplasm of human colon cancer HT29 cells, and its distribution pattern shifts from perinuclear granular enrichment to diffuse cytoplasmic localization over time[1].
NIK-12192 potently inhibits the proliferation of human colon cancer cell lines at 72 h (IC50 = 1.06-2.58 μM), and its activity varies across other human tumor cell lines[1].
NIK-12192 (5 μM; 24-72 h) induces progressive detachment of human colon cancer HT29 cells from the matrix. The floating cells remain viable for up to 48 h and retain partial re-adhesion capacity[1].
NIK-12192 (0.05-0.2 μM; 2 h-7 days) inhibits colony formation in human colon cancer cells in a time-dependent manner[1].
NIK-12192 (0.1-1 μM; 3-4 days) inhibits the colony growth of human colon cancer cells without inducing cytostatic effects[1].
NIK-12192 (5 μM; 24-96 h) does not alter the expression level of ανβ5 integrin, but induces the polarization of ανβ5 integrin on the plasma membrane of the human colon cancer cell line HT29[1].
NIK-12192 (2 μM; 24 h) reduces the intracellular pH of H460 cells from approximately 7.2 to approximately 6.2[2].
NIK-12192 (2 μM; 24 h) does not alter the expression of vacuolar H+-ATPase, but induces a shift in its localization from a punctate pattern to a diffuse cytoplasmic distribution in H460 cells[2].
NIK-12192 (0.5-2 μM) inhibits the migration of H460 cells in a concentration-dependent manner without affecting cell adhesion[2].
NIK-12192 (0.5-2 μM; 24 h pretreatment, plus continuous exposure during the 24 h invasion assay) inhibits the invasion of H460 cells in a concentration-dependent manner without affecting cell adhesion[2].
NIK-12192 (0.5 μM; 48 h) reduces the wound healing capacity of H460 cell monolayers[2].
NIK-12192 (2 μM; 24 h) induces the transition of αvβ3 integrin from a polarized distribution to a uniform cytoplasmic distribution in H460 cells[2].
NIK-12192 (2 μM; 24 h) disrupts the cytoskeletal structures of actin and tubulin in H460 cells, including actin filament fragmentation, disappearance of pseudopodia, and disorganization of tubulin filament architecture[2].
NIK-12192 (0.5-2 μM; 24-72 h) inhibits the three-dimensional growth of H460 cell spheroids in a concentration-dependent manner[2].
NIK-12192 (5 μM; 24-120 h) induces delayed apoptosis (apparent after 72 h) and significant necrosis in human colon cancer HT29 cells[1].
NIK-12192 (5 μM; 24-96 h) induces a delayed reduction in the mitochondrial membrane potential of human colon cancer HT29 cells, an effect that first appears at 72 h of treatment[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only. Further protocols information, click here.
-
Cell Line:human colon carcinoma HT29 cells
-
Concentration:1 μM
-
Incubation Time:20 min; 120 min
-
Result:Showed predominantly perinuclear localization, forming a narrow fluorescence ring and very intense granules often with polar localization after 20 min.
Decreased overall emission signal, with diffuse fluorescence distributed throughout the cytoplasm after 120 min.
-
Cell Line:human colon carcinoma cells
-
Concentration:0.05 and 0.2 μM
-
Incubation Time:7 days (long-term); 2 h (short-term)
-
Result:Reduced colony formation to 52% of control levels with long-term treatment of 0.05 μM.
Reduced colony formation to 34% of control levels with long-term treatment of 0.2 μM.
Reduced colony formation to 93% of control levels with short-term treatment of 0.05 μM.
Reduced colony formation to 66% of control levels with short-term treatment of 0.2 μM.
-
Cell Line:human colon carcinoma HT29 cells
-
Concentration:5 μM
-
Incubation Time:24 h; 48 h; 72 h; 96 h; 120 h
-
Result:Induced signs of early apoptosis only after 72 h of treatment.
Induced late apoptosis at longer treatment times.
Induced a high extent of necrotic cell death detected via PI permeability.
-
Cell Line:human nonsmall cell lung carcinoma H460 cells
-
Concentration:2 μM
-
Incubation Time:24 h
-
Result:Showed no change in vacuolar H+-ATPase expression relative to untreated control cells.
Revealed vacuolar H+-ATPase shifted from cytoplasmic spots in control cells to more homogeneously and diffusely distributed in the cytoplasm of treated cells.
-
Cell Line:human nonsmall cell lung carcinoma H460 cells
-
Concentration:0.5, 1 and 2 μM
-
Incubation Time:24 h pretreatment, plus continuous exposure during 5 h migration assay
-
Result:Caused a concentration-dependent inhibition of H460 cell migration.
Showed no effect on cell adhesion at tested concentrations.
-
Cell Line:human nonsmall cell lung carcinoma H460 cells
-
Concentration:0.5, 1 and 2 μM
-
Incubation Time:24 h pretreatment, plus continuous exposure during 24 h invasion assay
-
Result:Caused a concentration-dependent inhibition of H460 cell invasion.
Showed no effect on cell adhesion at tested concentrations.
-
Cell Line:human nonsmall cell lung carcinoma H460 cells
-
Concentration:2 μM
-
Incubation Time:24 h
-
Result:Induced a shift of αvβ3 integrin from polarized cytoplasmic localization in control cells to more homogeneous diffuse distribution in treated cells.
In Vivo
NIK-12192 (30 mg/kg; p.o.; 5 times per week for 7 weeks) shows no inhibitory effect on experimental lung metastasis in female athymic nude CD-1 mice intravenously injected with H460 non-small cell lung cancer cells[2].
NIK-12192 (30 mg/kg; oral administration; once daily; for 2 weeks) causes a slight reduction in tumor microvessel density in female athymic nude CD-1 mice inoculated with subcutaneous H460 non-small cell lung cancer xenografts[2].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:CD-1 (female, 8 to 11 weeks old, s.c. inoculation of H460 ascitic tumor cells)[2]
-
Dosage:30 mg/kg
-
Administration:p.o.; daily 5 times/week; 9 weeks
-
Result:Reduced mean number of macroscopic lung metastases to 15, representing a 42% inhibition compared to control mice.
Partially inhibited growth of primary s.c. tumors.
Caused no lethal toxicity or body weight loss greater than 5%.
-
Animal Model:CD-1 (female, 8 to 11 weeks old, i.v. injection of H460 ascitic tumor cells)[2]
-
Dosage:30 mg/kg
-
Administration:p.o.; daily 5 times/week; 7 weeks
-
Result:Showed no relevant difference in metastatic burden between treated and control mice; all treated mice developed a large metastatic burden similar to controls.
Caused no lethal toxicity or body weight loss greater than 5%.
-
Animal Model:CD-1 (female, 8 to 11 weeks old, s.c. inoculation of H460 ascitic tumor cells)[2]
-
Dosage:30 mg/kg
-
Administration:p.o.; daily; 2 weeks
-
Result:Marginally reduced tumor angiogenesis; inhibited microvessel density by 30% compared to control tumors, with the reduction not statistically significant.
Caused no lethal toxicity or body weight loss greater than 5%.
Chemical Information
-
CAS No. 318262-42-9
-
Molecular Weight 488.45
-
Formula C26H31Cl2N3O2
-
SMILES
O=C(C1=CC(OCC)=C(C2=CC3=CC(Cl)=C(C=C3N2)Cl)C=C1)NC4CC(C)(C)NC(C)(C4)C
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Protocols
-
Scratch/Wound-Healing Migration Assay
The scratch/wound-healing migration assay measures collective migration of adherent cells into an experimentally created cell-free gap in a confluent monolayer. The readout is generated by imaging the gap immediately after scratching and at later time points, then quantifying reduction in wound area, wound width, or percentage closure as cells move into the denuded region. Gap closure reflects cell migration but may also include cell proliferation, so interpretation should distinguish migration-focused conditions from proliferation-driven closure when possible, such as by using short assay windows, serum-controlled conditions, cell counting, or proliferation controls reported in published protocols.
-
Mitochondrial membrane-potential fluorescent assay
Mitochondrial membrane potential fluorescent assays estimate ΔΨm in living cells using lipophilic cationic dyes such as TMRM, TMRE, rhodamine 123, and JC-1, which accumulate in mitochondria according to membrane polarization; loss of signal after FCCP or CCCP treatment is interpreted as mitochondrial depolarization. TMRM/TMRE and rhodamine 123 are commonly used for semi-quantitative live-cell microscopy or flow cytometry, while JC-1 can report a shift from red aggregate fluorescence to green monomer fluorescence during depolarization; interpretation requires controls because dye concentration, quenching mode, cell type, dye efflux, and mitochondrial mass can affect fluorescence independently of ΔΨm.
-
Annexin V plus membrane-impermeant dye apoptosis staining
Annexin V-based apoptosis assays rely on the detection of phosphatidylserine (PS) externalization from the inner leaflet of the plasma membrane to the outer leaflet, an early biochemical hallmark of apoptosis. Fluorescently labeled Annexin V binds PS in a calcium-dependent manner, enabling identification of early apoptotic cells by flow cytometry or fluorescence microscopy. When combined with a membrane-impermeant DNA-binding dye (e. g. , propidium iodide), this approach allows discrimination between viable (Annexin V−/dye−), early apoptotic (Annexin V+/dye−), and late apoptotic or necrotic (Annexin V+/dye+) cell populations by assessing membrane integrity and PS exposure.
-
Cell migration
Cell migration is a method that plays an important role in wound healing, cell differentiation, embryonic development, etc.
-
Neural Crest/Neuronal Cell Migration Explant Assay
Neural crest (NC) and neuronal cell migration explant assays are in vitro systems in which neural tube-derived tissues are cultured to allow premigratory or newly emigrated neural crest cells to undergo epithelial-to-mesenchymal transition (EMT), migrate away from the explant, and form a measurable radial outgrowth that reflects migratory capacity and environmental responsiveness. These assays typically quantify migration by measuring the expansion of cell outgrowth from neural tube or neural plate border explants over time, often comparing early and later timepoints to derive a migration index such as a radius ratio, which reflects net cell dispersal from the explant core. Neural tube explant cultures preserve key aspects of neural crest behavior, including EMT, migration, and early differentiation, making them suitable for assessing intrinsic migratory ability and extrinsic cue dependence. However, studies emphasize that migratory outgrowth from neural tube explants may include non-n
-
Breast Cancer Modeling
Breast cancer is a heterogeneous cancer, and it has been distinguished into four subtypes: luminal A, luminal B, HER2-positive and basal-like. Molecular mutations, epigenetic alterations, hormone exposure and immune microenvironment are related to the progression of breast cancer.
-
Phalloidin F-actin cytoskeleton staining
Phalloidin F-actin staining detects polymerized filamentous actin in fixed and permeabilized specimens by using fluorescent phalloidin or phalloidin-derived phallotoxins that bind actin filaments and generate a fluorescence microscopy readout corresponding to F-actin organization, including stress fibers, cortical actin, filament bundles, and tissue-specific actin networks. Phalloidin stabilizes F-actin by reducing actin subunit dissociation from filament ends, and fluorescent phallotoxins were established as tools for visualizing actin-containing structures in eukaryotic cells.
-
Apoptosis
Apoptosis, also called programmed cell death, is generally characterized by distinct morphological characteristics.
-
TUNEL staining for apoptotic DNA fragmentation
TUNEL staining detects DNA strand breaks by using terminal deoxynucleotidyl transferase to add labeled nucleotides to exposed 3′-OH DNA termini, generating either microscopic staining in fixed cells or tissue sections, or fluorescence/cytometric signal in cell suspensions. TUNEL positivity reflects DNA fragmentation but should not be interpreted alone as definitive apoptosis, because TUNEL can also label necrotic, autolytic, mechanically damaged, or DNA-repair-associated DNA breaks.
-
Chemotaxis Gradient Chamber Assay 1
The chemotaxis gradient chamber assay is based on the principle of observing directional cell migration in response to a stable, linear or quasi-linear concentration gradient of a chemoattractant formed between two fluid reservoirs separated by a narrow observation chamber. Cells placed within the chamber respond to the gradient by polarized movement toward higher chemoattractant concentrations, allowing quantification of chemotactic behavior in real time under microscopy. The classic Zigmond chamber design enables simultaneous visualization of gradient formation and individual cell trajectories, making it suitable for studying leukocyte chemotaxis and other motile cell types in vitro.
-
Under-Agarose Cell Migration Assay
The under-agarose cell migration assay is a classical in vitro chemotaxis method designed to evaluate directed cell movement through a semi-solid agarose matrix toward soluble chemoattractant gradients, enabling visualization and quantification of leukocyte or motile cell migration in a confined 2D-like environment. In this system, cells and chemoattractants are placed in separate wells cut into an agarose gel, allowing diffusion-driven gradient formation that guides directional migration, which is typically assessed by measuring migration distance, cell morphology changes, and accumulation toward the chemoattractant source. This assay has been widely used to study neutrophil and leukocyte chemotaxis as a simple alternative to filter-based migration systems and allows direct microscopic observation of migrating cells under near-physiological confinement conditions.
-
Fluorescent plasma-membrane potential dye assay
Fluorescent plasma-membrane potential dye assays measure changes in cell membrane potential using voltage-sensitive dyes whose fluorescence changes when cells depolarize or hyperpolarize. Anionic bis-oxonol dyes such as DiBAC4(3) enter depolarized cells more readily and show increased fluorescence after intracellular binding, while hyperpolarization reduces dye accumulation and fluorescence. FMP/FLIPR membrane-potential dyes are used for faster, homogeneous microplate assays of ion-channel or receptor-mediated membrane-potential changes.
-
Transwell/Boyden Chamber Migration Assay
The Transwell/Boyden chamber migration assay measures cell movement through a porous membrane separating an upper and lower chamber, usually after a chemoattractant gradient is established by placing cells in the upper chamber and chemoattractant-containing medium in the lower chamber. The readout is generated by quantifying cells that traverse the membrane and appear on the lower membrane surface or in the lower chamber, depending on whether the cell type is adherent or non-adherent. This assay reflects chemotactic or haptotactic migration rather than matrix invasion unless an extracellular-matrix barrier is added to the membrane.
-
Mitochondrial membrane-potential and mitochondrial mass staining
Mitochondrial membrane potential staining measures the electrochemical polarization across the mitochondrial inner membrane in live cells using lipophilic cationic fluorescent probes; early rhodamine-based work showed that selective mitochondrial dye accumulation is lost when the mitochondrial transmembrane potential is dissipated. JC-1 reports mitochondrial polarization by shifting from green monomer fluorescence to red J-aggregate fluorescence as dye concentration increases within energized mitochondria; therefore, the red/green fluorescence ratio is used as a relative readout of mitochondrial membrane potential. TMRE or TMRM staining provides a single-channel relative readout because these cationic rhodamine esters accumulate in polarized mitochondria, and lower fluorescence indicates reduced mitochondrial polarization when acquisition and dye-loading conditions are controlled. Mitochondrial mass staining is commonly performed with MitoTracker Green FM or related MitoTracker dyes as
-
Tail-Vein Experimental Metastasis Xenograft
Tail-vein experimental metastasis xenograft models assess the ability of injected tumor cells to survive circulation, arrest in vascular beds, extravasate, and colonize distant organs, most commonly lung after lateral tail-vein injection; this model bypasses primary-tumor formation, local invasion, and intravasation, so the readout reflects late metastatic colonization rather than the full metastatic cascade. The main readouts are metastatic burden measured by bioluminescence imaging, gross metastatic nodules, histology, organ weight, survival, or ex vivo tumor-cell quantification; luciferase-labeled tumor cells permit longitudinal noninvasive monitoring, while histology confirms organ colonization and tissue localization.
-
Apoptosis Solutions
Apoptosis is a regulated, generally non-lytic cell-death pathway that removes unwanted, damaged, infected, or abnormal cells through coordinated morphological changes, caspase activation, DNA fragmentation, and membrane remodeling. The intrinsic apoptosis pathway is controlled mainly by mitochondrial outer membrane permeabilization, BCL-2 family proteins, cytochrome c release, apoptosome formation, caspase-9 activation, and downstream executioner caspase-3/7 activation. The extrinsic apoptosis pathway is initiated by death receptors such as Fas, TNFR, and TRAIL receptors, which recruit adaptor proteins and activate caspase-8 before engaging executioner caspases or mitochondrial amplification through BID cleavage. Apoptosis is linked to many phenotypes, including cancer cell killing, tissue homeostasis, immune regulation, neurodegeneration, infection response, and treatment-induced cytotoxicity; unresolved questions include how apoptosis interacts with necroptosis, pyroptosis, ferroptos
-
3D Collagen/Hydrogel Matrix Migration Assay
The 3D collagen/hydrogel matrix migration assay is based on embedding cells within or on top of a fibrillar collagen type I-rich three-dimensional matrix to model in vivo-like extracellular matrix (ECM) architecture, enabling analysis of cell migration through a physically and biochemically relevant scaffold. In contrast to 2D migration systems, cells in 3D matrices interact with fibrillar collagen networks, requiring coordinated adhesion remodeling and proteolytic or non-proteolytic deformation mechanisms to move through confined spaces, thereby providing a more physiologically relevant readout of invasive and migratory behavior in tissue-like environments. Cell movement in 3D collagen matrices is typically quantified by tracking single-cell trajectories, invasion depth, or matrix penetration over time, reflecting combined effects of cytoskeletal dynamics, cell-ECM adhesion turnover, and ECM remodeling. These systems are widely used to study tumor cell invasion and stromal cell motili
-
Cell invasion
Cell invasion is the ability of cells to migrate from one area to another via the extracellular matrix. Cell invasion is the response of normal and cancer cells to chemical and mechanical stimuli. Before migrating to a new region, the extracellular matrix is degraded by proteases within the cell. Cell invasion often occurs during wound repair, vascularization and inflammation, abnormal tissue invasion, and tumor cell metastasis.
-
Lysosome and acidic-vesicle live-cell staining
Lysosome and acidic-vesicle live-cell staining detects acidic intracellular compartments by using membrane-permeant acidotropic probes that accumulate in low-pH vesicles, including lysosomes, late endosomes, autolysosomes, and acidic phagosomes. LysoTracker staining is commonly used as an intensity-based readout of acidic lysosomal compartment abundance or enlargement, while acridine orange produces green fluorescence in less concentrated compartments and red fluorescence after concentration-dependent accumulation in acidic vesicular organelles. Loss or reduction of acridine-orange red signal can be used as a readout of lysosomal membrane permeabilization or reduced acidic-vesicle integrity. This protocol is designed for live cultured cells and can be adapted for fluorescence microscopy, high-content imaging, plate-reader readout, or flow cytometry when the selected literature supports the readout. Because these dyes report acidotropic accumulation rather than lysosome identity alone,
-
Cell-Exclusion Zone Migration Assay
The Cell-Exclusion Zone (CEZ) migration assay is an in vitro 2D cell migration method in which a defined cell-free area is created using removable physical barriers such as silicone stoppers, allowing cells to be seeded around the barrier and subsequently migrate into the cleared zone after barrier removal. This approach enables quantification of collective cell migration by monitoring repopulation of the initially cell-free region over time using microscopy-based imaging. Compared with scratch-based wound healing assays, barrier-based exclusion methods are designed to avoid mechanical damage to the extracellular matrix and reduce injury-induced effects on boundary cells, thereby improving interpretability of migration behavior in vitro. The assay readout is typically the progressive reduction in the cell-free area or the number of cells invading the exclusion zone, reflecting coordinated cell motility relevant to physiological processes such as wound healing, epithelial repair, and ca
-
Chemotaxis Gradient Chamber Assay 2
Chemotaxis gradient chamber assays measure directional cell migration in response to a soluble chemical gradient by imaging cells as they move across a defined observation region; the readout is generated from time-lapse cell trajectories, displacement toward the gradient, forward migration index, trajectory plots, rose/polar plots, and statistical tests of non-random directionality. The Dunn chamber is a direct-viewing glass chamber in which cells migrate across a bridge between control and chemoattractant wells, allowing observation of cells in a linear concentration gradient; related direct-viewing formats include the Insall chamber, which supports defined unidirectional gradients and high numerical-aperture microscopy, and the μ-Slide Chemotaxis chamber, which supports long-term live-cell imaging and gradient characterization with fluorescent dye.
-
Orthotopic Cell-Line Xenograft
Orthotopic cell-line xenograft models involve implantation of human cancer cell lines into the anatomically corresponding organ of immunodeficient mice to reproduce tumor growth within a native microenvironment, enabling more clinically relevant tumor behavior compared with subcutaneous models. These models are widely used because orthotopic placement better recapitulates tumor progression, including invasion and metastatic spread, which are often underrepresented in heterotopic implantation systems. Compared with conventional xenografts, orthotopic implantation is described as more technically complex but provides improved simulation of tumor-microenvironment interactions and metastatic behavior, making it particularly valuable for translational oncology research. Surgical orthotopic implantation approaches have been emphasized as enabling faithful reproduction of clinical cancer features, including metastasis and disease progression patterns that align with the tumor’s organ of origi
Purity & Documentation
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)